Commentary

An Explanation about Ketamine, Etomidate and Their Combination for Induction of Anesthesia in Congenital Heart Disease

Abstract

  No Abstract 

[1] Dua N, Bhalotra AR. Induction of anaesthesia in cyanotic heart diseases: 'Ketomidate' to the rescue! Indian J Anaesth. 2018; 62:237.
[2] Strumpher J, Jacobsohn E. Pulmonary hypertension and right ventricular dysfunction: Physiology and perioperative management. J Cardiothorac Vasc Anesth. 2011; 25(4): 687–704
[3] Maxwell BG, Jackson E. Role of Ketamine in the Management of Pulmonary Hypertension and Right Ventricular Failure. J Cardiothorac Vasc Anesth. 2012; 26(3):24-25
[4] Sarkar M, Laussen PC, Zurakowski D, Shukla A, Kussman B, Odegard KC. Hemodynamic responses to etomidate on induction of anesthesia in pediatric patients. Anesth Analg. 2005; 101(3):645-50
[5] Ogawa K, Tanaka S, Murray P A. Inhibitory Effects of Etomidate and Ketamine on Endothelium-dependent Relaxation in Canine Pulmonary Artery. Anesthesiology; 2001; 94(4): 668-77.
Files
IssueVol 8 No 2 (2022): Spring QRcode
SectionCommentary
DOI https://doi.org/10.18502/aacc.v8i2.9164
Keywords
Ketamine Etomidate congenital heart disease Cyanotic heart diseases

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Jabbari A, Banihashem N. An Explanation about Ketamine, Etomidate and Their Combination for Induction of Anesthesia in Congenital Heart Disease. Arch Anesth & Crit Care. 2022;8(2):176-177.